Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study.
Iwahashi M, Inoue H, Matsubara T, Tanaka T, Amano K, Kanamono T, Nakano T, Uchimura S, Izumihara T, Yamazaki A, Karyekar CS, Takeuchi T. Iwahashi M, et al. Among authors: izumihara t. Mod Rheumatol. 2014 Nov;24(6):885-91. doi: 10.3109/14397595.2014.881954. Epub 2014 Apr 7. Mod Rheumatol. 2014. PMID: 24708204 Clinical Trial.
An investigation of the correlation between blood concentration of mizoribine and its efficacy in treatment of rheumatoid arthritis based on indices of drug survival and improvement in DAS28-CRP.
Ohtsubo H, Ohkura S, Akimoto M, Arishima Y, Sunahara N, Izumihara T, Eiraku N, Yoshitama T, Matsuda T. Ohtsubo H, et al. Among authors: izumihara t. Mod Rheumatol. 2012 Nov;22(6):837-43. doi: 10.1007/s10165-012-0611-3. Epub 2012 Mar 6. Mod Rheumatol. 2012. PMID: 22391858
Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders.
Amano K, Matsubara T, Tanaka T, Inoue H, Iwahashi M, Kanamono T, Nakano T, Uchimura S, Izumihara T, Yamazaki A, Karyekar CS, Takeuchi T; Japan Abatacept Study Group. Amano K, et al. Among authors: izumihara t. Mod Rheumatol. 2015 Sep;25(5):665-71. doi: 10.3109/14397595.2015.1012786. Mod Rheumatol. 2015. PMID: 25698370 Free article.
Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.
Matsubara T, Katayama K, Sagawa A, Yoshida M, Mitsuka T, Hashimoto K, Izumihara T, Kondo M, Izumiyama T, Miyake N, Yoshii I, Oribe M, Momohara S, Funahashi K. Matsubara T, et al. Among authors: izumihara t. Mod Rheumatol. 2024 Feb 26;34(2):307-312. doi: 10.1093/mr/road027. Mod Rheumatol. 2024. PMID: 36943727
Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier.
Ijichi S, Matsuda T, Maruyama I, Izumihara T, Kojima K, Niimura T, Maruyama Y, Sonoda S, Yoshida A, Osame M. Ijichi S, et al. Among authors: izumihara t. Ann Rheum Dis. 1990 Sep;49(9):718-21. doi: 10.1136/ard.49.9.718. Ann Rheum Dis. 1990. PMID: 2241290 Free PMC article.